We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Upper tribunal Tax and Chancery decision of Mr Justice Richards and Judge Ashley Greenbank on 12 April 2024
Bringing together data from disparate systems helps identity the highest-risk vehicles.
Remarks by Sarah Cardell, CEO of the CMA, delivered during the 72nd Antitrust Law Spring Meeting. Washington DC, USA.
Upper Tribunal tax and Chancery decision of Judge Phyllis Ramshaw and Judge Nicholas Paines on 05 April 2024
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Employment Tribunal decision.
Minister for Development Andrew Mitchell spoke at the summit on using the UK's international development white paper to make global health a priority.
The CMA is investigating the anticipated acquisition by Barratt Developments plc of Redrow plc.
Employment Appeal Tribunal Judgment of Judge Auerbach on 14 March 2024.
The CMA is reviewing the Rail, Road and Inland Waterway Transport Block Exemption Regulation
Employment Appeal Tribunal Judgment of Judge Tayler on 7 March 2024.
The Chancellor has today (4 March) announced a significant investment package in the UK’s life sciences and manufacturing sectors.
Legislation being introduced will make regulations more effective and maintain the UK as an attractive place to market veterinary medicines
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).